The elevation of circ-Ttc3 expression protected cardiomyocytes against ischemia-related apoptotic death, while its downregulation aggravated cardiac dysfunction after MI, which seemed to be possible for the diagnostic and therapeutic targeting circ-Ttc3 in patients with ischemic heart disease (IHD). The gene discussed is TTC3; the disease is coronary artery disorder.